U.S. market Closed. Opens in 5 hours 58 minutes

AVRO | AVROBIO, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for AVRO we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is very bad and Health is weak.

Valuation (52%)

Company Industry
P/E Ratio (TTM) 2.07 -22.01
PEG Ratio (TTM) 0.01 15.69
P/S Ratio (TTM) 1.46 48.43
P/B Ratio (TTM) 0.71 18.71
P/FCF Ratio (TTM) -0.10 -2.79
Price to 5YR AVG Earnings Ratio -0.65 -3.21
Price to 5YR AVG FCF Ratio -0.06 -8.75

Profitability (100%)

Company Industry
ROA (TTM) 32.82% -5.02%
ROE (TTM) 29.68% 16.95%
Net Profit Margin (TTM) 842.30% -1,552.13%
ROIC 5YR AVG 3,531.54% 14.51%

Growth (40%)

4QTR AVG 3YR AVG 5YR AVG
EPS 82.54% 5.11% 27.70%
Revenue -25.00% N/A N/A
Net Income 82.40% -39.74% 0.43%
Cash Flow 13.95% -41.65% -17.83%

Health (49%)

Company Industry
Current Ratio (TTM) 26.17 6.08
Quick Ratio (TTM) 25.87 5.80
D/E Ratio (TTM) 0.00 -15.32
Interest Coverage (TTM) 12.81 -1.96
Piotroski F-Score 4 5
Altman Z-Score N/A 13.86
LTL to 5YR AVG FCF N/A 0.16
Shares Outstanding Growth 5YR AVG 31.59% 128.58%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙